Abstract
For several years, some IRAK-4 inhibitors have been developed to treat chronic lymphocytic leukemia; however, their interaction with the IRAK-4 kinase is unclear. The aim of this study was to evaluate the interaction of some amine and furanone derivatives with IRAK-4 as a therapeutic alternative to treat chronic lymphocytic leukemia. The theoretical coupling of amine and furanone derivatives with the IRAK-4 was carried out using the 5uit protein as a theoretical model. Besides, 1-439 PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib drugs were used as controls in the DockingServer program. The results displayed different types of amino acid residues involved in the interaction of amine and furanone derivatives with the 5uit protein surface compared to the controls. Besides, the inhibition constant was lower for amino derivatives 3, 9, 25, 33, and 36 compared with the controls. Other data indicate that the inhibition constant was lower for furanone analogs 1, 3, 7, 13, 27, 32, and 34 compared with PF-3758309, 336113-53-2, 509093-47-4, ND-2158, and emavusertib. In conclusion, theoretical data indicate that amine (3, 9, 25, 33, and 36) and furanones (1, 3, 7, 13, 27, 32, and 34) derivatives might have a higher affinity for the 5uit protein surface compared with the controls. This data suggests that both amino and furanone derivatives can act as IRAK-4 inhibitors, which may serve to treat chronic lymphocytic leukemia.

This publication has 49 references indexed in Scilit: